SNTI
Senti Biosciences Inc
0.3293$
-4.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +30.6% | +0.0% | -100.0% | – | – | -100.0% | – | – | – | -27.3% | +6.3% | – | |
| – | -94.3% | -0.9% | +0.4% | – | – | – | – | -38.8% | -1.2% | – | – | – | |
| – | -678.0% | – | – | – | – | – | – | – | – | – | -4,162.5% | – | |
| – | +0.3% | -6.6% | +4.4% | -2.7% | -12.9% | +23.1% | +5.6% | +7.3% | -26.2% | -31.9% | +47.1% | – | |
| – | -17.1% | -2.8% | -38.1% | +39.0% | +56.0% | -29.7% | +5.5% | -15.0% | +1.6% | -1.4% | +16.9% | – | |
| – | -61.6% | -12.5% | -19.9% | +28.0% | -3.3% | +11.5% | -6.6% | +10.6% | -25.0% | -9.4% | +20.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -1,922.3% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.